基于“脾为生痰之源、肺为贮痰之器”论培土生金法在肺癌咳嗽治疗中的应用
Application of Strengthening Earth to Generate Metal Therapy for Lung Cancer Cough Based on the Theory of “Spleen as Phlegm Source and Lung as Phlegm Reservoir”
摘要: 肺癌作为全球发病率和死亡率最高的恶性肿瘤,咳嗽是其最常见的伴随症状之一,严重降低患者生活质量。中医“脾为生痰之源、肺为贮痰之器”理论揭示了痰饮生成与贮藏的核心病机。本文基于该经典理论,系统探讨培土生金法(健脾以绝生痰之源、益气以充肺金之本)在肺癌咳嗽治疗中的理论依据、临床应用及阶段化策略。研究认为,肺癌患者因手术、放化疗、情志抑郁等因素导致脾失健运、水湿停聚,聚湿成痰上贮于肺,引发咳嗽咳痰、气短乏力等症。培土生金法通过恢复脾运功能、充养肺气,标本兼顾,是现代肺癌咳嗽症状管理中不可或缺的中医治疗策略。
Abstract: Lung cancer ranks first in terms of incidence and mortality worldwide among all malignant tumors. Cough is one of its most common accompanying symptoms, which seriously impairs patients’ quality of life. The traditional Chinese medicine (TCM) theory that “the spleen is the source of phlegm production, and the lung is the container storing phlegm” reveals the core pathogenesis of the generation and accumulation of phlegm-fluid. Based on this classical theory, this paper systematically discusses the theoretical basis, clinical application and staged strategies of the method of strengthening earth to generate metal (invigorating the spleen to cut off the source of phlegm production, tonifying qi to enrich the root of lung metal) in the treatment of cough in lung cancer. The study holds that lung cancer patients may suffer from impaired spleen transportation, retention of water-dampness, and phlegm accumulated in the lung due to surgery, radiotherapy and chemotherapy, emotional depression and other factors, leading to symptoms such as cough with expectoration, shortness of breath and lassitude. By restoring the transporting function of the spleen and nourishing lung qi, the method of strengthening earth to generate metal addresses both the root cause and symptoms, serving as an indispensable TCM therapeutic strategy for modern symptom management of cough in lung cancer.
文章引用:曹欣悦, 熊绍权. 基于“脾为生痰之源、肺为贮痰之器”论培土生金法在肺癌咳嗽治疗中的应用[J]. 中医学, 2026, 15(10): 449-454. https://doi.org/10.12677/tcm.2026.1510578

参考文献

[1] Siegel, R.L., Giaquinto, A.N. and Jemal, A. (2024) Cancer Statistics, 2024. CA: A Cancer Journal for Clinicians, 74, 12-49.
https://doi.org/10.3322/caac.21820
[2] Harle, A., Molassiotis, A., Buffin, O., Burnham, J., Smith, J., Yorke, J., et al. (2020) A Cross-Sectional Study to Determine the Prevalence of Cough and Its Impact in Patients with Lung Cancer: A Patient Unmet Need. BMC Cancer, 20, Article No. 9.
https://doi.org/10.1186/s12885-019-6451-1
[3] 田佳月, 黎雪, 原苏芮, 等. 林洪生教授从五脏论治肺癌相关性咳嗽的经验[J]. 世界中医药, 2023, 18(5): 668-672.
[4] 宋丽君, 刘杰, 任似梦, 等. 220例肺癌患者胸部放疗结束时的症状负担和症状群研究[J]. 世界科学技术-中医药现代化, 2023, 25(6): 2140-2146.
[5] 田雪琪, 戴悦宁, 吴冠锦, 等. 基于全程管理理念探究肺癌手术康复期患者证-症特征演变及用药规律[J]. 中成药, 2025, 47(7): 2456-2461.
[6] 陈子佳, 韩宇, 刘欣, 等. 基于大模型的肺癌表皮生长因子受体突变患者生存预测模型构建与验证[J]. 世界中医药, 2025, 20(8): 1379-1390.
[7] 蒋凤仙, 禚孝丽, 赖靖江, 等. 非小细胞肺癌驱动基因突变的中医辨证分型研究进展[J]. 辽宁中医杂志, 2024, 51(5): 201-205.
[8] 杨昕, 李和根, 周蕾, 等. 中医药干预早期非小细胞肺癌的临床效果研究[J]. 世界中医药, 2024, 19(15): 2339-2345.
[9] 亓奥, 焦丽静, 王怡超, 等. 早期肺癌术后巩固康复期的中药用药规律研究[J]. 中成药, 2023, 45(10): 3487-3492.
[10] 丁彤晶, 念家云, 张佳慧, 等. 基于数据挖掘的王笑民教授治疗非小细胞肺癌的用药规律[J]. 世界中医药, 2023, 18(17): 2524-2530.
[11] 李可可, 徐义峰, 张亮, 等. 基于“阳化气, 阴成形”理论探讨国医大师洪广祥治疗晚期肺癌临证经验[J]. 中华中医药杂志, 2025, 40(3): 1203-1206.
[12] 张思雨, 李晓斌, 喻明, 等. 基于肺脾肾“五行相生”理论论治肺癌[J]. 中国实验方剂学杂志, 2023, 29(15): 172-178.
[13] 刘坤, 王辉, 杨宗艳. 杨宗艳基于五脏生克规律论治肺癌经验[J]. 辽宁中医杂志, 2024, 51(10): 15-18.
[14] 段海婧, 宁艳梅, 吴国泰, 等. 非小细胞肺癌中医证型及用药规律的网络构建及可视化分析[J]. 中药药理与临床, 2023, 39(10): 87-92.
[15] 龙麟, 梁欣, 张叶熙, 等. 基于虚劳“三本两统”理论辨治肺癌探析[J]. 中国中医基础医学杂志, 2023, 29(8): 1391-1393.
[16] 邹冬侠, 杨闯, 张腊梅, 等. 自拟四君子汤合消风散加减治疗非小细胞肺癌的预后研究[J]. 辽宁中医杂志, 2023, 50(6): 140-143.
[17] 王文雯, 李仝, 李哲, 等. 祛毒扶正汤联合紫杉醇化疗方案治疗Ⅳ期非小细胞肺癌的疗效[J]. 辽宁中医杂志, 2024, 51(11): 107-111.
[18] 褚雪镭, 陈美池, 李颖, 等. 海花调肺方治疗早期肺癌术后伴肺部多发亚厘米磨玻璃结节疗效观察[J]. 中药新药与临床药理, 2023, 34(8): 1151-1155.
[19] 丁欢, 陈卓, 于洪鹏, 等. 炙甘草汤加减联合PD-1 治疗晚期NSCLC(气阴两虚型)的疗效[J]. 中国肿瘤临床, 2024, 51(9): 461-466.
[20] 姜晓晨, 张传龙, 刘福栋, 等. 朴炳奎病证结合诊治肺癌经验撷要[J]. 中华中医药杂志, 2023, 38(12): 5865-5870.